LC
JAZZ icon

Lindbrook Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Lindbrook Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$61.1K Buy
492
+103
+26% +$13.4K 0.01% 906
2024
Q4 		$47.9K Buy
389
+176
+83% +$20.7K ﹤0.01% 831
2024
Q3 		$23.7K Buy
213
+45
+27% +$4.93K ﹤0.01% 1200
2024
Q2 		$17.9K Buy
168
+33
+24% +$3.63K ﹤0.01% 1306
2024
Q1 		$16.3K Sell
135
-3
-2% -$367 ﹤0.01% 1322
2023
Q4 		$17K Sell
138
-22
-14% -$2.75K ﹤0.01% 1272
2023
Q3 		$20.7K Buy
160
+5
+3% +$666 ﹤0.01% 1045
2023
Q2 		$19.2K Sell
155
-45
-23% -$6.05K ﹤0.01% 1111
2023
Q1 		$29.3K Buy
200
+42
+27% +$6.21K ﹤0.01% 897
2022
Q4 		$25.2K Buy
158
+63
+66% +$9.23K ﹤0.01% 955
2022
Q3 		$13K Hold
95
– – ﹤0.01% 1200
2022
Q2 		$15K Hold
95
– – ﹤0.01% 1097
2022
Q1 		$15K Buy
95
+4
+4% +$580 ﹤0.01% 1128
2021
Q4 		$12K Buy
91
+59
+184% +$7.75K ﹤0.01% 1201
2021
Q3 		$4K Buy
32
+3
+10% +$453 ﹤0.01% 1314
2021
Q2 		$5K Buy
29
+8
+38% +$1.39K ﹤0.01% 1288
2021
Q1 		$3K Hold
21
– – ﹤0.01% 1426
2020
Q4 		$3K Sell
21
-37
-64% -$5.51K ﹤0.01% 1342
2020
Q3 		$8K Buy
58
+21
+57% +$2.6K ﹤0.01% 912
2020
Q2 		$4K Buy
37
+18
+95% +$1.99K ﹤0.01% 1171
2020
Q1 		$2K Sell
19
-22
-54% -$2.84K ﹤0.01% 1297
2019
Q4 		$6K Hold
41
– – ﹤0.01% 1062
2019
Q3 		$5K Hold
41
– – ﹤0.01% 1072
2019
Q2 		$5K Buy
41
+19
+86% +$2.55K ﹤0.01% 1062
2019
Q1 		$3K Hold
22
– – ﹤0.01% 1167
2018
Q4 		$2K Buy
+22
New +$3.26K ﹤0.01% 1177

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Lindbrook Capital's JAZZ Position: Q1 2025 in Review

Lindbrook Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 26% in Q1 2025, buying an estimated $13.4K and bringing the position to 492 shares worth $61.1K. The position accounts for 0.01% of the portfolio, ranked #906.

Lindbrook Capital first reported a position in JAZZ in Q4 2018 and has held it in 26 quarters since. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • Lindbrook Capital held 492 shares of Jazz Pharmaceuticals worth $61.1K as of Q1 2025.
  • Lindbrook Capital bought 103 Jazz Pharmaceuticals shares in Q1 2025, an estimated $13.4K.
  • Jazz Pharmaceuticals made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #906 holding.
  • Lindbrook Capital first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 26 quarters since.
  • 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.